ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,714Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 978

$1.12M Total Retail Price of All Prescriptions

Rank: 5 out of 978

460 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 15,034 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 929 789 1 2
NAMENDA 825 789 2 45
LISINOPRIL 823 690 3 1
WARFARIN SODIUM 658 472 4 11
DONEPEZIL HCL 607 590 5 26
OMEPRAZOLE 603 506 6 3
CITALOPRAM HBR 547 477 7 14
LEVOTHYROXINE SODIUM 506 457 8 4
MIRTAZAPINE 465 449 9 31
METOPROLOL TARTRATE 445 403 10 10
FUROSEMIDE 438 368 11 9
TRAZODONE HCL 371 302 12 18
GABAPENTIN 362 301 13 15
SERTRALINE HCL 313 246 14 21
AMLODIPINE BESYLATE 303 277 15 6
ATENOLOL 287 259 16 8
METFORMIN HCL 243 193 17 7
GALANTAMINE HBR 226 185 18 149
QUETIAPINE FUMARATE 215 174 19 51
ALENDRONATE SODIUM 210 202 20 20
ATORVASTATIN CALCIUM 206 177 21 12
METOPROLOL SUCCINATE 201 144 22 13
HYDROCHLOROTHIAZIDE 178 168 23 5
DIGOXIN 171 146 24 54
OLANZAPINE 149 136 25 75
TAMSULOSIN HCL 146 134 26 33
DIVALPROEX SODIUM 139 134 27 56
ADVAIR DISKUS 135 104 28 35
LANTUS 128 70 29 40
LOSARTAN POTASSIUM 127 116 30 22
ROPINIROLE HCL 126 95 31 138
FLUOXETINE HCL 106 57 32 42
ISOSORBIDE MONONITRATE ER 100 66 33 57
CARVEDILOL 88 68 34 55
SEROQUEL 86 69 35 113
ESCITALOPRAM OXALATE 84 73 36 117
DIOVAN 83 75 37 43
RISPERIDONE 81 62 38 49
POTASSIUM CHLORIDE 79 65 39 41
VENLAFAXINE HCL ER 78 68 40 86
ALLOPURINOL 77 50 41 34
PANTOPRAZOLE SODIUM 73 73 42 39
TRAMADOL HCL 73 62 42 24
ABILIFY 71 54 44 106
BUPROPION HCL SR 70 57 45 115
CLOPIDOGREL 69 62 46 61
CUBICIN 69 69 46 292
EXELON 68 68 48 162
SPIRIVA 67 54 49 37
RANITIDINE HCL 67 41 49 27
FLUTICASONE PROPIONATE 67 51 49 28
VESICARE 66 66 52 157
PREDNISONE 66 61 52 47
TRIAMTERENE-HCTZ 64 64 54 67
LOPERAMIDE 64 60 54 236
LEVOFLOXACIN 59 55 56 98
LEVETIRACETAM 59 52 56 93
LOVASTATIN 58 45 58 29
ZOLPIDEM TARTRATE 56 53 59 32
FENOFIBRATE 54 46 60 53
OXYCODONE HCL 54 33 S2 60 23
NYSTOP 53 39 62 118
FLOVENT HFA 53 51 62 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.